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Aims To investigate the local, regulatory role of the mucosa on bladder strip contractility 
from normal and overactive bladders and to examine the effect of botulinum toxin A (BoNT-
A). 
Methods Bladder strips from Spontaneously Hyperactive Rat (SHR) or normal rats (Sprague 
Dawley, SD) were dissected for myography as intact or mucosa-free preparations. 
Spontaneous, neurogenic and agonist-evoked contractions were investigated. SHR strips 
were incubated in BoNT-A (3 hours) to assess effects on contractility. 
Results Spontaneous contraction amplitude, force-integral or frequency were not 
significantly different in SHR mucosa-free strips compared with intacts. In contrast, 
spontaneous contraction amplitude and force-integral were smaller in SD mucosa-free strips 
than in intacts; frequency was not affected by the mucosa. Frequency of spontaneous 
contractions in SHR strips was significantly greater than in SD strips. 
Neurogenic contractions in mucosa-free SHR and SD strips at higher frequencies were 
smaller than in intact strips. The mucosa did not affect carbachol-evoked contractions in 
intact vs mucosa-free strips from SHR or SD bladders.  
BoNT-A reduced spontaneous contractions in SHR intact strips; this trend was also 
observed in mucosa-free strips but was not significant. Neurogenic and carbachol-evoked 
contractions were reduced by BoNT-A in mucosa-free but not intact strips. Depolarization-
induced contractions were smaller in BoNT-A treated mucosa-free strips. 
Conclusions The mucosal layer positively modulates spontaneous contractions in strips 
from normal SD but not overactive SHR bladder strips. The novel finding of BoNT-A 
reduction of contractions in SHR mucosa-free strips indicates actions on the detrusor, 





Local control of bladder contractility by cells in the mucosal layer which include urothelium, 
lamina propria interstitial cells (IC-LP), nerves, smooth muscle and microvessels is 
increasingly recognised (1). In vitro myography of bladder strips has been widely used to 
decipher the contribution of the tissue layers in the bladder wall to contractility of the strip. 
The influence of urothelial and lamina propria components which collectively comprise the 
mucosa, on spontaneous, neurogenic and agonist-evoked contractions is dependent on 
complex signalling processes.  
Intrinsic, non-voiding or spontaneous contractions occur in normal, healthy bladders during 
filling and contribute to the maintenance of optimal bladder tone (2). Experimentally, 
spontaneous contractions in ex vivo bladder strips from human or rodent bladders are 
regarded to be representative of non-voiding contractions, which are pronounced in 
pathophysiologies. Intact strips exhibit robust spontaneous contractions; interestingly 
mucosal and detrusor layers separated by sharp dissection also have spontaneous 
contractions (4, 5). Smooth muscle in the mucosa known as muscularis mucosae has 
physiological and pharmacological properties that are distinct from detrusor smooth muscle 
and have been reported for some species but not rat (3, 4). Muscularis mucosae 
contractions may act to periodically move the urothelium layer, preventing prolonged contact 
with elements in the urine; moreover, it is reported that muscularis mucosal contraction 
directly contributes to the contractility of guinea-pig intact strips (3).  
Cells within the mucosal layer release signalling molecules which modulate bladder strip 
contraction. Purinergic receptor-mediated (5) and muscarinic receptor-mediated release of 
ATP (6) from urothelial cells is reportedly associated with mucosal layer contraction. The 
urothelium also exerts an inhibitory influence on bladder strip contractility and several groups 
have noted the existence of an urothelium derived inhibitory factor, UDIF. Hawthorn et al. (7) 
reported smaller carbachol-evoked contractions in intact strips of pig bladder compared with 
mucosa-free strips; moreover, mucosa-free strip contractions were inhibited by the presence 
of a second intact strip indicating release of a modulatory signal. The exact identity of this 
diffusible UDIF is not yet known although several candidates have been proposed and 
excluded (8). 
 
Botulinum toxin type A (BoNT-A) is used to treat anti-muscarinic refractory detrusor 
overactivity (DO) where involuntary detrusor contractions can be observed and overactive 
bladder syndrome (OAB) where DO may or may not be demonstrable (9). The established 
mechanism of action of BoNT-A on neurones involves cleavage of synaptosome-associated 
protein-25 (SNAP-25), a component of the neuronal SNARE complex, preventing neuronal 
transmitter release. It is likely that there are other targets of BoNT-A in the bladder which 
contribute to its effect on OAB symptoms including an effect on sensory bladder function. In 
spinal cord injured (SCI) rats, BoNT-A significantly reduced ATP release into the bladder 
lumen, presumably from the urothelium (10) and in patients with neurogenic and idiopathic 
detrusor overactivity, BoNT-A decreased expression of sensory receptors P2X3 and TRPV1 
(11). SNAP-25 expression has been identified in human and mouse urothelium and BoNT-A 
was found to inhibit ATP release from urothelial cells (12). In contrast, in another study, 
SNAP-25 was not detected in human urothelial or muscle cells but in nerve fibres that 
permeated the urothelium and muscle layers (13). 
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Increased expression of Cx26 and Cx43 gap junction proteins on urothelial cells and IC-LP 
respectively in SCI rat overactive bladder was consistent with the ability of gap junction 
uncouplers to inhibit spontaneous activity (14). Reduced Cx43 expression in patients with 
DO treated with BoNT-A may indicate that IC-LP are affected by BoNT-A (15).  A study on 
suburothelial vs intradetrusor BoNT-A injection in patients found that both modes were 
similarly effective (16).  
We hypothesize that BoNT-A may have multiple, cellular targets of action in the bladder wall.  
The aims of the present study were to: (1) investigate the impact of the mucosa on 
spontaneous, neurogenic and carbachol-evoked contractions in normal and overactive 
bladder using the spontaneously hypertensive rat (SHR, 17) and (2) determine whether 
BoNT-A has a direct effect on these contractile parameters in intact and mucosa-free strips 








Male SHRs (18-20 weeks, N=18) were purchased from Charles River Laboratories 
International Inc. and male Sprague Dawley rats (18 weeks, N=12) were purchased from 
Harlan UK and were sacrificed by cervical dislocation or CO2 inhalation in accordance with 
Schedule 1 Animal (Scientific Procedures) Act (UK Home Office), European Directive 
2010/63/EU and local ethical committee approval.  Bladders were removed, opened 
longitudinally and pinned to a Sylgard dissecting dish.  The trigone was removed and the 
bladder body was divided longitudinally. In one half, the mucosal layer was removed by 
sharp dissection under a dissecting microscope and the underlying detrusor layer cut into 
four strips (10mm x 2mm x 2mm); four full-thickness strips were prepared from the remaining 
half.   
In vitro myography 
Bladder strips were mounted vertically in organ bath chambers, attached by thread at one 
end to tension transducers and by thread at the other end to a fixed point. Tissues were 
continually perfused (2 ml.min-1) with oxygenated (95% O2/5% CO2, 37oC) Krebs’ solution 
(mM: 120 NaCl, 5.9 KCl, 11 glucose, 25 NaHCO3, 1.2 Na2HPO4, 1.2 MgCl2, 2.5 CaCl2). An 
initial tension of 1g was applied and the strips left to equilibrate for 1 hour during which time 
spontaneous contractions typically developed. 
Bladder strips were stimulated with carbachol (1 µM, 5 min), ATP (5mM, 3 min) or 60mM K+ 
in addition to stimulation of intramural nerves via electrical field stimulation (EFS, 70V, 0.3ms 
pulse width, 10s duration over the frequency range 0.5, 1, 2, 4, 8, 16Hz).  Spontaneous 
activity and stimulation responses were recorded using Intracept Chart v4.9 software and 
analysed as contraction amplitude and force-integral Area Under Curve (AUC) using 
Clampfit v10.3 and Prism v5.0 (GraphPad) software. A 5 minute portion of the recording 
where spontaneous activity was established, prior to the perfusion of any agonists, was used 
for analysis. For amplitude and frequency measurement, a threshold was set which was 
10% of the maximal contraction amplitude above the baseline; mean amplitude and 
frequency over the 5 minutes was calculated for each strip. Contractions in response to 
carbachol, ATP or 60mM K+ were measured as AUC over 3 minutes from contraction onset. 
Data are presented as scatter plots with median indicated for spontaneous activity figures or 
as box and whisker plots showing median, interquartile range and minimum/maximum 
values. N and n denote number of animals and strips respectively. Data sets from strips 
were compared with Mann Whitney tests or for EFS protocols, two-way ANOVA with 
Bonferroni post-hoc test using Prism with P<0.05 considered as significant (P<0.05, P<0.01 
and P<0.001 are denoted as *, ** and *** respectively on graphs). 
Incubation with botulinum toxin A 
Tissue strips from SHR bladders were assigned to control or treatment groups. In the 
treatment group, tissues were incubated in BoNT-A (30nM, Botox®, Allergan) reconstituted 
with HEPES-Krebs’ solution (mM: 125 NaCl, 5.36 KCl, 11 glucose, 10 HEPES, 0.44 
KH2PO4, 0.33 NaH2PO4, 1 MgCl2, 1.8 CaCl2) for 3 hours in a tissue culture incubator (37 ºC, 
humidified 20% O2).  Control group tissues were incubated in HEPES-Krebs’ solution in the 




Spontaneous activity and mucosal modulation 
Tissue strips from SHR overactive (17) and Sprague Dawley (SD) normal bladders typically 
developed spontaneous activity during the equilibration period. This activity was insensitive 
to tetrodotoxin (1μM) confirming its non-neurogenic nature. Representative examples are 
shown in Figure 1a for activity in intact and mucosa-free strips from each animal model. The 
summary data demonstrates that in SHR strips, absence of the mucosal layer did not affect 
AUC, average amplitude or frequency (P>0.05; N=15, intact n=23, mucosa-free n=20 
(Figure 1b, P>0.05). In SD bladders, spontaneous activity AUC and amplitude were smaller 
in mucosa-free strips (Figure 1c, P=0.02 and P=0.003 respectively; N=8, n=15 intact, n=15 
mucosa-free) whereas frequency was not affected (P>0.05).  
Comparison of the data between strains demonstrated that the frequency of spontaneous 
contractions was smaller in both intact and mucosa-free strips from SD vs SHR bladders 
(P=0.005 and P=0.004 respectively). Contraction amplitude was not different in intact or 
mucosa-free strips and AUC was smaller in mucosa-free SD strips (P=0.01). 
Contractions evoked by carbachol 
Application of carbachol (1 μM) evoked similar contractions in SHR intact (N=9, n=14) and 
mucosa-free (N=9, n=14) tissues (Figure 2a) (P>0.05). Similarly, in SD bladder, carbachol-
evoked contractions were not different whether or not the mucosal layer was present (N=8, 
n=16 intact and mucosa-free, P>0.05). Summary data is presented in Figure 2b. Responses 
to carbachol were not significantly different between strains either for intact or mucosa-free 
strips (P>0.05). 
Neurogenic contractions 
Electrical field stimulation was used to evoke neurogenic contractions across a frequency 
range (0.5, 1, 2, 4, 8, 16Hz). These responses were sensitive to tetrodotoxin (1μM) 
confirming their neurogenic origin. Neurogenic contraction amplitude in SHR mucosa-free 
strips (N=11, n=18) at the higher frequencies (8 and 16 Hz) was significantly smaller than in 
intact strips (N=11, n=18) (P<0.01) indicating that the mucosal layer contributed positively to 
contraction amplitude (Figure 3a, b). In the normal rat SD bladder, neurogenic contractions 
were also significantly smaller in intact strips (N=4, n=7) compared with mucosa-free strips 
(N=4, n=7) at 8Hz (P<0.01) and 16Hz (P<0.001, Figure 3c, d).  
The effect of botulinum toxin A on contractions in SHR bladder strips 
Intact and mucosa-free SHR strips were incubated in 30nM BoNT-A for 3 hours as described 
in methods (18). Smith et al. (10) and van Uhm et al. (19) used similar protocols to treat 
normal bladder tissues with BoNT-A; it has been suggested that BoNT-A may reach cells 
within the bladder wall via endocytosis and transcytosis (12). In this series of experiments, 
control tissues were treated in the same fashion but with the omission of BoNT-A. 
Contractions were generally smaller after the 3 hour incubation although they were within the 
range of values reported for experiments in figures 1-3. Spontaneous activity was reduced 
by BoNT-A (Figure 4a, b) in intact strips as measured by AUC (N=4, n=4 control; N=6, n=6 
treated; P=0.026). In mucosa-free strips, AUC was reduced by BoNT-A however this was 
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not significant. Contraction frequency was not affected by BoNT-A in intact or mucosa-free 
strips (P>0.05).  
Carbachol-evoked contractions (Figure 4c, d) were significantly reduced by BoNT-A in 
mucosa-free strips (n=7 (N=7) control, n=11 (N=9) treated; P<0.05) whereas these were not 
affected in intact strips (n=6, N=6 control; n=12, N=10 treated; P>0.05). The shape of 
carbachol responses was similar in BoNT-A treated and untreated strips however, the 
magnitude was markedly smaller. ATP-evoked contractions in mucosa-free strips were not 
significantly affected by incubation in BoNT-A (n=7, N=7 control; n=11, N=9 treated). 
Depolarisation-induced contractions by 60mM external K+ solution, were reduced by BoNT-A 
in mucosa-free strips (P<0.05) indicating that smooth muscle contraction was negatively 
impacted. Interestingly, depolarization-evoked contractions in intact strips were not 
significantly affected by BoNT-A (P>0.05), suggesting that mucosal signalling may have 
masked the effect on mucosa-free contraction. 
Neurogenic-contractions were significantly reduced by BoNT-A (Figure 5a, b) in mucosa-
free strips at 4, 8 and 16 Hz (N=6, n=7 control; N=9, n=11 treated; P<0.05) whereas those in 








The present study has shown that the mucosal layer provides a positive contribution to 
myogenic spontaneous activity in normal SD rat bladder but not in the overactive model, 
SHR. Little is known of SHR bladder strip contractility; overactivity of the SHR bladder itself 
is considered to be due to both peripheral and spinal mechanisms with a defect in 
noradrenergic control of micturition reflexes (17). The smooth muscle content of the SHR 
bladder wall is reportedly similar to normal rat bladder with no difference in the size, 
orientation or spacing of smooth muscle bundles (20). Non-contractile elements of the SHR 
bladder mucosa were reported to exhibit hypertrophy including increased type I collagen, a 
higher number of inflammatory cells and larger suburothelial spaces. Our findings show that 
spontaneous activity in SHR is of significantly higher frequency than in SD strips. In normal 
bladder models, the effect of mucosal layer removal (lamina propria and urothelium) or 
removal of only the urothelium on bladder strip contractility has been reported. In a study of 
normal SD rat bladder strips, spontaneous contraction amplitude was apparently smaller in 
strips with urothelium removed compared with intacts (statistics not reported in 18). This 
phenomenon has also been reported for guinea-pig bladder where removal of the mucosa 
resulted in reduced mucosa-free strip spontaneous activity (3). There may be contractile 
elements within the mucosal layer which contribute to the larger activity in intact bladder 
strips; in guinea-pig bladder, this has been attributed to muscularis mucosae smooth muscle 
contraction (3); however, this is perhaps unlikely to be the case in the present study given 
that such a tissue layer has not been reported for rat bladder (4). An explanation for 
enhanced activity in normal bladder intact strips may involve release of excitatory factors 
such as ATP from the mucosal layer which would act to enhance contraction of the detrusor 
smooth muscle (5, 6).  
Neurogenic contractions 
Our observation that removal of the mucosal layer reduced neurogenic contraction amplitude 
of SHR and normal bladder strips at all frequencies, with these differences being significant 
at higher frequencies. The mechanisms underlying this observation are not understood but it 
may be related to the relative proportions neurotransmitters where purinergic mechanisms 
are thought to be dominant at the lower frequencies and a larger cholinergic component at 
higher frequencies. Our finding that that carbachol-contractions were similar in intact and 
mucosa-free strips in SHRs consistent with Schneider et al. (22), indicates that expression of 
cholinergic receptors across the SHR bladder wall does not account for the neurogenic 
contraction difference. The findings in the present study for normal bladder are consistent 
with (23) which reported that neurogenic contractions were smaller in urothelium-free strips. 
Aronsson et al. (24) reported that TTX-sensitive neurogenic contractions in normal SD 
bladders were similar in intact and urothelium-free strips where the urothelium had been 
removed by collagenase treatment and mechanical scraping. The mode of removal of the 
urothelial layer by rubbing or the entire mucosa (urothelium and lamina propria) by sharp 
dissection as per the present study may account for some of the differences in observations 




In both SHR and normal bladder, carbachol-evoked contractions were similar in intact and 
mucosa-free strips indicating that the mucosal layer did not make a significant contribution. 
This is consistent with the finding of similar relative contributions of muscarinic receptor 
subtypes and muscarinic receptor-mediated contractions in SHR bladders compared with 
controls (22). In keeping with the present study, Aronsson et al. (24) found carbachol 
contractions over the range 10 nM–0.1 mM to be similar in mucosa-free and intact SD strips. 
In contrast (21) reported that intact SD strips were less sensitive to carbachol and concluded 
the mucosa exerted an inhibitory influence. Again, the opposite was reported by Munoz et al 
(23) who found carbachol-contractions to be smaller in urothelium-free strips. There are 
likely to be several reasons for differences in findings by independent groups which may 
include mode of removal of the mucosa; whether the lamina propria remained and the 
concentration range of carbachol used.  
The lack of effect of mucosal-removal in the present study on carbachol-evoked contractions 
may reflect a composite from concomitant removal of a mucosal-derived inhibitory factor and 
removal of mucosal contractile elements.  
Impact of BoNT-A on SHR contractility 
The benefits of BoNT-A treatment to anti-muscarinic-refractory DO and OAB syndrome are 
widely accepted. While the canonical mechanism of action of BoNT-A on neurons is well 
understood, it is likely that there are additional effects on other cells of the bladder wall that 
modulate bladder activity. We adopted similar methodology to test the effect of BoNT-A on 
bladder tissue to others where the mechanism of access to cells within the tissue is 
considered to be endocytosis and transcytosis during a 3 hour incubation (10, 12, 18, 19). In 
vivo injections of BoNT-A to guinea-pig bladders reportedly did not generate cSNAP-25+ 
fibres at 6 hours; between 12 and 24 hours was required for this mechanism (13). Our 
experimental design therefore enabled us to test BoNT-A on contractility independent of the 
canonical mechanism of action where the presence of cSNAP-25 is used as a marker of 
neurotoxin action. Our findings demonstrate that BoNT-A directly reduced spontaneous 
activity in intact and mucosa-free strips (although the latter did not reach significance) which 
may point to an action of BoNT-A on smooth muscle or interstitial cells to diminish 
spontaneous activity in the SHR model of overactive bladder. Furthermore, neurogenic 
contractions and carbachol-evoked contractions were decreased by BoNT-A in mucosa-free 
strips. A reduction of neurogenic contractions in mice treated with BoNT-A, 48 hours 
previously was also reported by Ikeda et al (25) and Takahashi et al (18) reported smaller 
contractions after BoNT-A incubation. Interestingly, the impact of BoNT-A on neurogenic and 
carbachol-evoked contractions was not found in intact strips indicating that BoNT-A was 
acting on cells in the detrusor and that its effect in intact strips may have been masked by 
inhibitory mucosal signalling. ATP-evoked contractions showed a trend towards reduction by 
BoNT-A, however, this was not significant. The finding that depolarization-induced 
contractions were reduced by BoNT-A in mucosa-free strips but not in intacts, was also 
consistent with the view that an action of BoNT-A on detrusor smooth muscle contraction 
was being masked by mucosal signalling.  
In conclusion, our findings demonstrate that the mucosal layer positively modulates 
spontaneous contractions in normal rat bladder strips but not in the overactive SHR model. 
An overall mucosal effect on carbachol-evoked contractions was not found in normal bladder 
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or SHR strips. The mucosal layer positively modulates higher frequency neurogenic 
contraction in strips from both strains.   
BoNT-A reduced spontaneous activity in SHR bladder strips and also reduced neurogenic, 
carbachol-evoked and depolarization-induced contractions in SHR mucosa-free strips 
indicating an action on the detrusor layer, independent of the mucosa.  This work reveals 
effects of BoNT-A on bladder contractility in addition to its classical effect on the neuronal 
SNARE complex. 
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Figure 1. Impact of the mucosal layer on spontaneous activity in overactive and 
normal rat bladder strips. 
a: Representative traces of spontaneous contractile activity in intact or mucosa-free strips 
from SHR (overactive) and SD (normal) rat bladder. 
b: Scatter plots (median denoted by line) of area under curve (AUC), average contraction 
amplitude and frequency in SHR bladder; these were not different in mucosa-free strips 
(intact n=23, N=15; mucosa-free n=20, N=15). 
c: AUC and contraction amplitude were smaller in mucosa-free SD strips; frequency was not 
affected by the presence/absence of the mucosa (intact n=15, N=8; mucosa-free n=15, 
N=8). Mann Whitney tests; * denotes P<0.05). 
 
Figure 2. Carbachol-evoked contractions are not impacted by the mucosal layer in 
SHR or SD  rat bladder strips. 
a: Representative traces of cholinergic contractions evoked by carbachol (1μM) in intact or 
mucosa-free strips from SHR (overactive) and SD (normal) rat bladder. 
b: Summary plots (median, interquartile range and min/max) of area under curve (AUC) in 
both animal models. Carbachol-contractions were similar in the presence and absence of the 
mucosal layer in SHR (intact and mucosa-free n=14, N=9) and normal SD (intact and 
mucosa-free n=16, N=8) strips (Mann Whitney tests; p>0.05).   
 
Figure 3. Neurogenic contractions are enhanced by the mucosal layer in SHR bladder 
strips 
a. Representative traces of electrical field stimulation (EFS) evoked contractions in intact 
and mucosa-free SHR bladder strips.  
b. Summary plots (median, interquartile range and min/max) of mean contraction amplitude 
at frequencies tested (n=18, N=11). EFS-contractions in mucosa-free strips were smaller at 
each frequency, this was significant at 8Hz and 16Hz (** p<0.01, 2 way ANOVA repeated 
measures, Bonferroni post-hoc test). 
c. Representative traces of EFS-evoked contractions in intact and mucosa-free SD bladder 
strips.  
d. Summary plots (median, interquartile range and min/max) of mean contraction amplitude 
at frequencies tested (n=7, N=4). EFS-contractions in mucosa-free strips were smaller at 
each frequency, this was significant at 8Hz and 16Hz (** p<0.01, *** p<0.001, 2 way ANOVA 
repeated measures, Bonferroni post-hoc test). 
 
Figure 4. Impact of BoNT-A incubation on spontaneous activity and agonist-evoked 
contractions in SHR strips 
a. Representative traces of spontaneous activity in mucosa-free SHR bladder strips in the 
presence and absence of BoNT-A. 
b. Summary plots (median, interquartile range and min/max) of mean spontaneous activity 
(AUC and amplitude) in intact and mucosa-free strips. Activity was smaller in the BoNT-A 
treated strips compared with controls (n=4, N=4 control; n=6, N=6 treated). Mann Whitney 
tests; * denotes P<0.05). 
c. Representative traces of contractions evoked by carbachol (1μM), ATP (5mM) and 60mM 
K+ in detrusor SHR strips, control and pre-incubated in BoNT-A. 
d. Summary plot (median, interquartile range and min/max) of mean evoked contractions 
(AUC) in mucosa-free strips by carbachol (1μM), ATP (5mM) or 60mM K
+
. Carbachol and 
K
+
-evoked contractions were smaller in the BoNT-A treated strips compared with controls 




Figure 5. Impact of BoNT-A incubation on neurogenic contractions in SHR mucosa-
free strips 
a. Representative traces of neurogenic-contractions in mucosa-free SHR bladder strips in 
the presence and absence of BoNT-A. 
b. Summary plots (median, interquartile range and min/max) of mean contraction amplitude 
where BoNT-A reduced contractions at each frequency tested (N=6, n=7 control; N=9, n=11 
treated; two-way ANOVA repeated measures, Bonferroni post-hoc test; * p<0.05, ** p<0.01). 
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